CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Revenue Growth by Quarter and Year

Mateon Therapeutics Inc's Revenue results by quarter and year




OXGN Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 1.40 - - -
I Quarter March 0.34 - - -
FY   1.74 - - -



OXGN Revenue second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved Revenue of $ 1.40 millions compare to recorded in same quarter a year ago.

Looking into second quarter results within Biotechnology & Drugs industry 9 other companies have achieved higher Revenue growth. While Mateon Therapeutics Inc' s Revenue no change of % ranks overall at the positon no. 67 in the second quarter.




OXGN Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Revenue $ 1.40 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Revenue $ 0.00 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Revenue Growth >>


OXGN Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 311.76 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #10
Healthcare Sector #29
Overall #67

Revenue Y/Y Growth Statistics
High Average Low
310.73 % 2.68 % -100 %
(Jun 30 2020)   (Dec 31 2013)
Revenue second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #10
Healthcare Sector #29
Overall #67
Revenue Y/Y Growth Statistics
High Average Low
310.73 % 2.68 % -100 %
(Jun 30 2020)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
310.73 % 2.68 % -100 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Revenue Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Revenue doubling of 311.76%, to $ 1.40 millions, from $0.34 millions in the first quarter.
OXGN is undergoing a remarkable growth, not just claiming better then average increase, but also accelerating pace, Destiny White, Biotechnology & Drugs industry consultant mentioned.

Within Biotechnology & Drugs industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Mateon Therapeutics Inc's Revenue growth quarter on quarter, overall rank is 67.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #10
Healthcare Sector #29
Overall #67
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #10
Healthcare Sector #29
Overall #67
Revenue Q/Q Growth Statistics
High Average Low
310.73 % 2.68 % -100 %
(Jun 30 2020)  


OXGN's II. Quarter Q/Q Revenue Comment
Mateon Therapeutics Inc achieved in the II. Quarter 2020 above company average sequential Revenue doubling of 311.76%, to $ 1.40 millions, from $0.34 millions in the first quarter.
OXGN is going from strength to strength, not only reporting above regular gain, and additionally accelerating rate.

Within Biotechnology & Drugs industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Mateon Therapeutics Inc's Revenue growth quarter on quarter, overall rank is 67.


Mateon Therapeutics Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Jun 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2020 period, Mateon Therapeutics Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OXGN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OXGN's Competitors
Revenue Growth for Mateon Therapeutics Inc's Suppliers
Revenue Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2020
Integrated Biopharma Inc -0.36 %$ -0.361 millions
Conformis Inc -0.64 %$ -0.638 millions
National Research Corporation -0.79 %$ -0.789 millions
Prestige Consumer Healthcare Inc -1.19 %$ -1.189 millions
Amedisys Inc -1.61 %$ -1.608 millions
Sanara Medtech Inc -1.67 %$ -1.667 millions
Endo International Plc -1.73 %$ -1.735 millions
Healthcare Services Group Inc -2.18 %$ -2.180 millions
Biolargo Inc -2.40 %$ -2.395 millions
Eli Lilly And Company -2.44 %$ -2.436 millions
Myomo Inc -2.47 %$ -2.472 millions
Icu Medical Inc -2.85 %$ -2.851 millions
Reliv International Inc -2.91 %$ -2.912 millions
United Therapeutics Corporation -3.10 %$ -3.105 millions
Immunogen inc -3.33 %$ -3.326 millions
Hologic Inc -3.46 %$ -3.461 millions
Nature s Sunshine Products inc -3.79 %$ -3.790 millions
Healthlynked Corp -3.88 %$ -3.880 millions
Laboratory Corporation Of America Holdings -3.92 %$ -3.918 millions
Steris Plc -4.00 %$ -4.000 millions
Medpace Holdings inc -4.25 %$ -4.254 millions
Baxter International Inc -4.30 %$ -4.296 millions
Universal Health Services Inc -4.39 %$ -4.393 millions
Irhythm Technologies Inc -4.60 %$ -4.600 millions
Clearpoint Neuro Inc -4.93 %$ -4.935 millions
Avanos Medical Inc -4.94 %$ -4.936 millions
Cancer Genetics Inc -5.18 %$ -5.180 millions
Adaptive Biotechnologies Corporation -5.19 %$ -5.195 millions
Atrion Corporation -5.32 %$ -5.324 millions
Lexicon Pharmaceuticals Inc -5.36 %$ -5.360 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CDXI's Profile

Stock Price

CDXI's Financials

Business Description

Fundamentals

Charts & Quotes

CDXI's News

Suppliers

CDXI's Competitors

Customers & Markets

Economic Indicators

CDXI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071